دورية أكاديمية

Zanubrutinib versus ibrutinib in symptomatic Waldenström macroglobulinemia : final analysis from the randomized phase III ASPEN study

التفاصيل البيبلوغرافية
العنوان: Zanubrutinib versus ibrutinib in symptomatic Waldenström macroglobulinemia : final analysis from the randomized phase III ASPEN study
المؤلفون: Dimopoulos, Meletios A., Opat, Stephen, D'Sa, Shirley, Jurczak, Wojciech, Lee, Hui-Peng, Cull, Gavin, Owen, Roger G., Marlton, Paula, Wahlin, Bjorn E., Garcia-Sanz, Ramon, McCarthy, Helen, Mulligan, Stephen, Tedeschi, Alessandra, Castillo, Jorge J., Czyz, Jaroslaw, Fernández de Larrea, Carlos, Belada, David, Libby, Edward, Matous, Jeffrey, Motta, Marina, Siddiqi, Tanya, Tani, Monica, Trneny, Marek, Minnema, Monique C., Buske, Christian, Leblond, Veronique, Treon, Steven P., Trotman, Judith, Chan, Wai Y., Schneider, Jingjing, Allewelt, Heather, Patel, Sheel, Cohen, Aileen, Tam, Constantine S.
سنة النشر: 2023
المجموعة: Jagiellonian University Repository
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0732-183X
1527-7755
العلاقة: Journal of Clinical Oncology, T. 41, nr 33, s. 5099-5106; https://ruj.uj.edu.pl/xmlui/handle/item/317304Test
DOI: 10.1200/jco.22.02830
DOI: 10.1200/JCO.22.02830
الإتاحة: https://doi.org/10.1200/jco.22.02830Test
https://ruj.uj.edu.pl/xmlui/handle/item/317304Test
رقم الانضمام: edsbas.2FAC1F48
قاعدة البيانات: BASE
الوصف
تدمد:0732183X
15277755
DOI:10.1200/jco.22.02830